{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:18:03Z","timestamp":1791195483078,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There are limited data regarding the amyloid positron emission tomography (PET) imaging among patients with Cerebral Amyloid Angiopathy (CAA). We sought to assess the amyloid load distribution detected on amyloid-PET among CAA patients compared to patients with Alzheimer\u2019s Disease (AD), patients with hypertension (HTN) related hemorrhage (ICH) and healthy controls (HC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis of published studies with available data on global and regional amyloid-PET uptake was conducted. Comparisons with respect to amyloid load distribution were investigated using random-effects models based on the ratio of mean (RoM) amyloid-PET uptake. RoM\u2009&amp;lt;\u20091 and RoM\u2009&amp;gt;\u20091 indicate lower and higher global or regional amyloid-PET uptake in CAA compared to another population, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 16 cohorts, comprising 271 CAA patients (mean age: 72\u2009years; women: 46%) versus 130 AD patients (mean age: 73\u2009years; women: 44%), 180 patients with HTN-related ICH (mean age: 66\u2009years; women: 36%) and 61 HC (mean age: 71\u2009years; women: 46%) with available data on amyloid-PET. Global amyloid PET ratio differentiated CAA from AD [RoM: 0.93; 95% CI: 0.90\u20130.96;\u2009p\u2009&amp;lt;\u20090.0001], HTN-related ICH [RoM: 1.25; 95% CI: 1.20\u20131.31;\u2009p\u2009&amp;lt;\u20090.0001], and HC [RoM: 1.26; 95% CI: 1.23\u20131.29;\u2009p\u2009&amp;lt;\u20090.0001]. Occipital amyloid-PET uptake [RoM: 1.20; 95% CI: 1.15\u20131.26;\u2009p\u2009&amp;lt;\u20090.0001] was higher in CAA compared to HTN-related ICH, and Occipital-to-global [RoM: 1.05; 95% CI: 1.03\u20131.07;\u2009p\u2009&amp;lt;\u20090.0001] ratio of amyloid-PET uptake differentiated also CAA from AD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CAA is characterized by a distinct amyloid-PET burden and distribution compared to AD patients, patients with HTN-related ICH and HC. These findings may contribute to the design and conduct of future randomized controlled clinical trials, aiming to treat CAA at preclinical stages.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/esj\/23969873251349657","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:01:42Z","timestamp":1768906902000},"source":"Crossref","is-referenced-by-count":3,"title":["Cerebral amyloid angiopathy and amyloid load distribution detected on amyloid\u2013positron emission tomography: A systematic review and meta-analysis"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-2610","authenticated-orcid":false,"given":"Aikaterini","family":"Theodorou","sequence":"first","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3224-3053","authenticated-orcid":false,"given":"Konstantinos","family":"Melanis","sequence":"additional","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Athanasaki","sequence":"additional","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7757-609X","authenticated-orcid":false,"given":"Lina","family":"Palaiodimou","sequence":"additional","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Ioanna","family":"Stefanou","sequence":"additional","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]},{"name":"Department of Neurology & Stroke , Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen ,","place":["Germany"]},{"name":"Hertie Institute for Clinical Brain Research , Eberhard-Karls University of T\u00fcbingen, T\u00fcbingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota-Eleni","family":"Tsalouchidou","sequence":"additional","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Vassilopoulos","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry , \u201cAiginition\u201d Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kouzoupis","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry , \u201cAiginition\u201d Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Themistocleous","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , Agia Sofia Children\u2019s Hospital, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios P","family":"Paraskevas","sequence":"additional","affiliation":[{"name":"Second Department of Neurology , \u201cAttikon\u201d University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Tzavellas","sequence":"additional","affiliation":[{"name":"First Department of Psychiatry , \u201cAiginition\u201d Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,1]]},"reference":[{"key":"2026012115124269900_bibr1-23969873251349657","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/brain\/awx047","article-title":"Emerging concepts in sporadic cerebral amyloid angiopathy","volume":"140","author":"Charidimou","year":"2017","journal-title":"Brain"},{"key":"2026012115124269900_bibr2-23969873251349657","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","article-title":"Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy","volume":"74","author":"Linn","year":"2010","journal-title":"Neurol"},{"key":"2026012115124269900_bibr3-23969873251349657","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou","year":"2022","journal-title":"Lancet Neurol"},{"key":"2026012115124269900_bibr4-23969873251349657","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(23)00114-X","article-title":"Progression of cerebral amyloid angiopathy: a pathophysiological framework","volume":"22","author":"Koemans","year":"2023","journal-title":"Lancet Neurol"},{"key":"2026012115124269900_bibr5-23969873251349657","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"2026012115124269900_bibr6-23969873251349657","first-page":"7247325","article-title":"The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: a neuropathological study","volume":"2019","author":"De Reuck","year":"2019","journal-title":"Neurol Res Int"},{"key":"2026012115124269900_bibr7-23969873251349657","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.3390\/jcm13237427","article-title":"Cognitive impairment in cerebral amyloid angiopathy: a single-center prospective cohort study","volume":"13","author":"Theodorou","year":"2024","journal-title":"J Clin Med"},{"key":"2026012115124269900_bibr8-23969873251349657","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1161\/STROKEAHA.121.035836","article-title":"Prevalence of clinical and neuroimaging markers in cerebral amyloid angiopathy: a systematic review and meta-analysis","volume":"53","author":"Malhotra","year":"2022","journal-title":"Stroke"},{"key":"2026012115124269900_bibr9-23969873251349657","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/23969873241260538","article-title":"CSF and plasma biomarkers in cerebral amyloid angiopathy: a single-center study and a systematic review\/meta-analysis","volume":"10","author":"Theodorou","year":"2025","journal-title":"Eur Stroke J"},{"key":"2026012115124269900_bibr10-23969873251349657","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/WNL.0000000000004539","article-title":"Amyloid-PET in sporadic cerebral amyloid angiopathy: a diagnostic accuracy meta-analysis","volume":"89","author":"Charidimou","year":"2017","journal-title":"Neurol"},{"key":"2026012115124269900_bibr11-23969873251349657","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nicl.2017.05.002","article-title":"Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: a systematic critical update","volume":"15","author":"Farid","year":"2017","journal-title":"NeuroImage Clin"},{"key":"2026012115124269900_bibr12-23969873251349657","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1212\/WNL.0b013e31826043a9","article-title":"Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy","volume":"79","author":"Gurol","year":"2012","journal-title":"Neurol"},{"key":"2026012115124269900_bibr13-23969873251349657","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ana.22099","article-title":"Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy","volume":"68","author":"Dierksen","year":"2010","journal-title":"Ann Neurol"},{"key":"2026012115124269900_bibr14-23969873251349657","article-title":"Cerebral microbleeds: prevalence and relationship to amyloid burden","volume":"92","author":"Graff-Radford","year":"2019","journal-title":"Neurol"},{"key":"2026012115124269900_bibr15-23969873251349657","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026012115124269900_bibr16-23969873251349657","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"2026012115124269900_bibr17-23969873251349657","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer Dement"},{"key":"2026012115124269900_bibr18-23969873251349657","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimer Dement"},{"key":"2026012115124269900_bibr19-23969873251349657","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0000000000003197","article-title":"Florbetapir-PET to diagnose cerebral amyloid angiopathy: a prospective study","volume":"87","author":"Gurol","year":"2016","journal-title":"Neurol"},{"key":"2026012115124269900_bibr20-23969873251349657","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2026012115124269900_bibr21-23969873251349657","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"2026012115124269900_bibr22-23969873251349657","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"2026012115124269900_bibr23-23969873251349657","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2026012115124269900_bibr24-23969873251349657","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v049.i05","article-title":"Closing the gap between methodologists and end-users:Ras a computational back-end","volume":"49","author":"Wallace","year":"2012","journal-title":"J Stat Softw"},{"key":"2026012115124269900_bibr25-23969873251349657","first-page":"1","article-title":"Conducting meta-analyses in r with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat CSoftw"},{"key":"2026012115124269900_bibr26-23969873251349657","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019","edition":"2nd ed."},{"key":"2026012115124269900_bibr27-23969873251349657","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2026012115124269900_bibr28-23969873251349657","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1038\/s41598-024-54243-1","article-title":"Differences in lobar microbleed topography in cerebral amyloid angiopathy and hypertensive arteriopathy","volume":"14","author":"Kuo","year":"2024","journal-title":"Sci Rep"},{"key":"2026012115124269900_bibr29-23969873251349657","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae086","article-title":"Cerebral tau pathology in cerebral amyloid angiopathy","volume":"6","author":"Tsai","year":"2024","journal-title":"Brain Commun"},{"key":"2026012115124269900_bibr30-23969873251349657","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/STROKEAHA.123.042835","article-title":"Cerebral microbleed patterns and cortical amyloid-\u03b2: the ARIC-PET study","volume":"54","author":"Okine","year":"2023","journal-title":"Stroke"},{"key":"2026012115124269900_bibr31-23969873251349657","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JAD-215094","article-title":"Role of white matter abnormalities in the relationship between microbleed Burden and cognitive impairment in cerebral amyloid angiopathy","volume":"86","author":"Jo","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"2026012115124269900_bibr32-23969873251349657","doi-asserted-by":"crossref","first-page":"721780","DOI":"10.3389\/fnagi.2021.721780","article-title":"Diagnostic utility of integrated11c-Pittsburgh compound B positron emission tomography\/magnetic resonance for cerebral amyloid angiopathy: a pilot study","volume":"13","author":"Chang","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"2026012115124269900_bibr33-23969873251349657","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/ene.14301","article-title":"Interhemispheric distribution of amyloid and small vessel disease burden in cerebral amyloid angiopathy-related intracerebral hemorrhage","volume":"27","author":"Planton","year":"2020","journal-title":"Eur J Neurol"},{"key":"2026012115124269900_bibr34-23969873251349657","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3233\/JAD-190625","article-title":"Florbetapir regional distribution in cerebral amyloid angiopathy and Alzheimer\u2019s disease: a PET study","volume":"73","author":"Planton","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"2026012115124269900_bibr35-23969873251349657","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00259-019-04314-7","article-title":"Clinical significance of amyloid \u03b2 positivity in patients with probable cerebral amyloid angiopathy markers","volume":"46","author":"Jang","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026012115124269900_bibr36-23969873251349657","article-title":"Microangiopathy underlying mixed-location intracerebral hemorrhages\/microbleeds: a pib-PET study","volume":"92","author":"Tsai","year":"2019","journal-title":"Neurol"},{"key":"2026012115124269900_bibr37-23969873251349657","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.0000000000004228","article-title":"Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages","volume":"89","author":"Raposo","year":"2017","journal-title":"Neurol"},{"key":"2026012115124269900_bibr38-23969873251349657","doi-asserted-by":"crossref","first-page":"44715","DOI":"10.1038\/srep44715","article-title":"Correlation of cerebral microbleed distribution to amyloid burden in patients with primary intracerebral hemorrhage","volume":"7","author":"Tsai","year":"2017","journal-title":"Sci Rep"},{"key":"2026012115124269900_bibr39-23969873251349657","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/jcbfm.2014.43","article-title":"Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage","volume":"34","author":"Baron","year":"2014","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026012115124269900_bibr40-23969873251349657","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.23830","article-title":"Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography\/magnetic resonance imaging study","volume":"73","author":"Gurol","year":"2013","journal-title":"Ann Neurol"},{"key":"2026012115124269900_bibr41-23969873251349657","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/WNL.0b013e3181cef7e3","article-title":"11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage","volume":"74","author":"Ly","year":"2010","journal-title":"Neurol"},{"key":"2026012115124269900_bibr42-23969873251349657","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Ann Neurol"},{"key":"2026012115124269900_bibr43-23969873251349657","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jnnp-2017-316851","article-title":"Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance","volume":"89","author":"Charidimou","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026012115124269900_bibr44-23969873251349657","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1093\/brain\/awad193","article-title":"Clinical considerations in early-onset cerebral amyloid angiopathy","volume":"146","author":"Banerjee","year":"2023","journal-title":"Brain"},{"key":"2026012115124269900_bibr45-23969873251349657","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ana.25560","article-title":"Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers","volume":"86","author":"Schultz","year":"2019","journal-title":"Ann Neurol"},{"key":"2026012115124269900_bibr46-23969873251349657","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1212\/WNL.0b013e318221ad36","article-title":"Cerebral microhemorrhage and brain \u03b2-amyloid in aging and Alzheimer disease","volume":"77","author":"Yates","year":"2011","journal-title":"Neurol"},{"key":"2026012115124269900_bibr47-23969873251349657","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s12149-025-02018-7","article-title":"Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer\u2019s disease patients","volume":"39","author":"Matsuda","year":"2025","journal-title":"Ann Nucl Med"},{"key":"2026012115124269900_bibr48-23969873251349657","article-title":"Association of memory impairment with concomitant Tau pathology in patients with cerebral amyloid angiopathy","volume":"96","author":"Schoemaker","year":"2021","journal-title":"Neurol"},{"key":"2026012115124269900_bibr49-23969873251349657","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/STROKEAHA.120.032905","article-title":"Brain glucose metabolism in cerebral amyloid angiopathy: an FDG-PET study","volume":"52","author":"Bergeret","year":"2021","journal-title":"Stroke"},{"key":"2026012115124269900_bibr50-23969873251349657","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/ene.14743","article-title":"[18F]FDG PET may differentiate cerebral amyloid angiopathy from Alzheimer\u2019s disease","volume":"28","author":"Bergeret","year":"2021","journal-title":"Eur J Neurol"},{"key":"2026012115124269900_bibr51-23969873251349657","article-title":"18FFlutemetamol-PET aided classification of cerebral amyloid angiopathy: a multicenter study","volume":"103","author":"Romoli","year":"2024","journal-title":"Neurol"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/1\/23969873251349657\/66195662\/23969873251349657.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/1\/23969873251349657\/66195662\/23969873251349657.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:17:15Z","timestamp":1769026635000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/doi\/10.1093\/esj\/23969873251349657\/8407738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/esj\/23969873251349657","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1,1]]},"article-number":"23969873251349657"}}